Key facts
- Notable investors include China Capital Management, Ganzhou Guohui Venture Capital Fund Management.
- Status: Privately Held (backing).
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Aobchem
- ·The full record, as it builds
Funding rounds
No funding rounds for Aobchem are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Aobchem
Manufacturer of medicinal chemistry and organic chemistry-based molecular building blocks intended for pharmaceutical developers, chemical research organizations, and users of fine chemical intermediates. The company is engaged in the research and production of molecular building blocks for pharmaceuticals and high-value fine chemical products, thereby enabling customers to conduct compound design, synthesis, and related research activities.
- Sector
- Healthcare
- HQ
- Zhuhai, China
- Founded
- 2016
- Employees
- 20
- Website
- aobchem.com.cn/
- Ownership
- Privately Held (backing)
Aobchem doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Aobchem shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Aobchem in its N-PORT filings yet. We sweep new filings monthly.